FGF19 and metabolic dysfunction-associated steatotic liver disease: The increased risk of developing NAFLD may be because cholecystectomy leads to decreased fibroblast growth factor 19, which affects cholesterol metabolism, causing triglycerides to accumulate in the liver [18].